BIOSENSE WEBSTER, INC.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1970-01-01
- Employees
- 1K
- Market Cap
- -
Clinical Trials
67
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (60 trials with phase data)• Click on a phase to view related trials
A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter
- Conditions
- Scar-related Atrial TachycardiaPersistent Atrial FibrillationParoxysmal Atrial FibrillationVentricular ProceduresVentricular TachycardiaIschemic Ventricular TachycardiaNon-ischemic Ventricular TachycardiaCardiomyopathyIdiopathic Ventricular TachycardiaPremature Ventricular Contraction
- First Posted Date
- 2025-08-11
- Last Posted Date
- 2025-08-11
- Lead Sponsor
- Biosense Webster, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT07116525
- Locations
- 🇧🇪
AZ Sint-Jan, Brugge, Belgium
🇧🇪Jessa Ziekenhuis, Hasselt, Belgium
🇫🇷Hopital les Franciscaines of Nimes, Nimes, France
Exploratory Safety and Effectiveness Evaluation of Pulsed Field Ablation (PFA) by Balloon Catheter With TRUPULSE Generator for Treatment of Paroxysmal Atrial Fibrillation (PAF)
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2024-07-10
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Biosense Webster, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT06495216
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2024-06-12
- Last Posted Date
- 2025-08-17
- Lead Sponsor
- Biosense Webster, Inc.
- Target Recruit Count
- 440
- Registration Number
- NCT06455098
- Locations
- 🇺🇸
Phoenix Cardiovascular Research Group, Phoenix, Arizona, United States
🇺🇸Mills Peninsula Health Services, Burlingame, California, United States
🇺🇸Scripps Clinic/Prebys Cardiovascular Institute, La Jolla, California, United States
A Study of the THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAFOUS
- Conditions
- Atrial Fibrillation
- First Posted Date
- 2024-02-22
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Biosense Webster, Inc.
- Target Recruit Count
- 135
- Registration Number
- NCT06272981
- Locations
- 🇦🇺
Royal Prince Alfred Hospital, Camperdown, Australia
🇦🇺Canberra Heart Rhythm, Garran, Australia
🇦🇺Westmead Hospital, Westmead, Australia
A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination
- Conditions
- Non-valvular Atrial FibrillationStrokeSystemic Embolism
- First Posted Date
- 2023-12-13
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- Biosense Webster, Inc.
- Target Recruit Count
- 1500
- Registration Number
- NCT06168942
- Locations
- 🇺🇸
Grandview Medical Center, Birmingham, Alabama, United States
🇺🇸Arizona Arrhythmia Research Group Phoenix Cardio Research Group PCRG, Phoenix, Arizona, United States
🇺🇸Tucson Medical Center, Tucson, Arizona, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 12
- Next